SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravir
Description
Solid organ transplant recipients (SOTR) constitute one of the groups at highest risk for the development of severe COVID-19. However, evidence on the effectiveness of treatments for SARS-CoV-2 infection in this group of patients is scarce
